Seller record · Telehealth service

Mevo Health

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 4 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The home page says medications are prepared by licensed 503A U.S. compounding pharmacies chosen by location, and the terms refer only to the Mevo Health Pharmacy Network or a pharmacy of the patient's choice. 3 more criteria also fail; see the table below.

At a glance

Mevo HealthTelehealth service

4/8criteria passed

Price: Semaglutide from $199 a month, tirzepatide from $259
Sells: compounded semaglutide injections, compounded tirzepatide injections
FDA letters: None on file

Visit Mevo Health See all eight dispositions

Telehealth service. Passes 4 of 8 criteria. Recorded against Standard v1.1.

A direct-pay telehealth weight loss service selling compounded semaglutide and tirzepatide injections on monthly, quarterly and six-month plans, with care from a network of board-certified physicians. Care starts with an online medical intake reviewed by a physician, and no pharmacy or postal address is printed.

Operating entity Mevo Health LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Mevo Health's website; Mevo Health's telehealth consent
S2	Prescription gating	PASS	Mevo Health's website; Mevo Health's refund policy
S3	Pharmacy identification	FAIL	Mevo Health's website; Mevo Health's terms and conditions; Mevo Health's refund policy
S4	Compounding disclosure	FAIL	Mevo Health's website; Mevo Health's terms and conditions; Mevo Health's telehealth consent
S5	Analytical documentation	FAIL	Mevo Health's website; Mevo Health's terms and conditions; Mevo Health's refund policy
S6	Business address	FAIL	Mevo Health's contact page; Mevo Health's terms and conditions; Mevo Health's privacy policy
S7	Price disclosure	PASS	Mevo Health's website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed physician from the Mevo Health medical network reviews each intake and decides whether treatment is appropriate, and the home page names four board-certified physicians, one of them the head of the provider network.Source: Mevo Health's website; Mevo Health's telehealth consent.

S2PASSThe home page lists a secure online health questionnaire as the first step, followed by a physician's review and a treatment plan, and says prescription products require an online consultation. The refund policy says intake and consultation fees are not refunded if a prescription is not approved.Source: Mevo Health's website; Mevo Health's refund policy.

S3FAILNo filling pharmacy is named. The home page says medications are prepared by licensed 503A U.S. compounding pharmacies chosen by location, and the terms refer only to the Mevo Health Pharmacy Network or a pharmacy of the patient's choice.Source: Mevo Health's website; Mevo Health's terms and conditions; Mevo Health's refund policy.

S4FAILThe home page sells compounded semaglutide and tirzepatide and says only that the FDA does not review compounded drugs for safety, effectiveness or quality before they are dispensed. No page, including the answers, the terms and the telehealth consent, states that the compounded medications are not FDA-approved.Source: Mevo Health's website; Mevo Health's terms and conditions; Mevo Health's telehealth consent.

S5FAILNo certificate of analysis or lot document is published on the home page, the terms or the refund policy.Source: Mevo Health's website; Mevo Health's terms and conditions; Mevo Health's refund policy.

S6FAILThe terms and the privacy policy name Mevo Health LLC, and no postal address appears on the contact page, in the footer, in the terms, in the privacy policy or in the refund policy, which give only an email address and a phone number. The terms name Delaware law.Source: Mevo Health's contact page; Mevo Health's terms and conditions; Mevo Health's privacy policy.

S7PASSCompounded semaglutide injections as low as $199 a month and compounded tirzepatide injections as low as $259, on plans offered monthly, quarterly or for six months.Source: Mevo Health's website.

S8PASSNo FDA warning letter names Mevo Health or Mevo Health LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injections, compounded tirzepatide injections.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit Mevo Health

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.